Clin2
NCT06924320Possibly a fitRecruiting

Study of two medicines for weight loss and diabetes

Obesity and Obesity-related Medical Conditions

Part of Hormones & metabolism clinical trials.

This study tests two investigational medications, MET233 and MET097, in people with obesity or overweight, with or without type 2 diabetes. It aims to see if the combination can help with weight loss and blood sugar control.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
381 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are between 18 and 75 years old.
  • Your BMI is between 27 and 45 (for most parts of the study).
  • You are generally healthy, with no major medical conditions (except possibly type 2 diabetes, sleep apnea, high blood pressure, or high cholesterol in some parts).
  • You are not pregnant, breastfeeding, or planning to become pregnant; you are willing to use birth control if needed.
  • You have not had weight loss surgery, been in a weight loss program in the last 3 months, or taken certain medications that could interfere.
  • You do not have type 1 diabetes or a history of pancreatitis, certain thyroid cancers, or serious mental health conditions.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07566390Recruiting· Phase 1
Testing a new weight-loss medicine in healthy adults

This early-stage study tests a new experimental medicine (NNC0113-5840) to see how it works in people who are overweight or have obesity. Researchers want to understand how the body processes this medicine and whether it's safe before testing it more widely.

Glendale, California
NCT07533175Recruiting· Phase 3
Testing a new weight-loss medicine for type 2 diabetes

This study tests whether a new medicine called NNC0487-0111 helps people with type 2 diabetes and excess weight lose weight. You'll take the medicine along with your current diabetes care to see if it works better than standard treatment.

Birmingham, Alabama
NCT07098663Recruiting· Phase 2
Study of MKP10241 for weight loss and diabetes control

This study tests an investigational drug called MKP10241 in healthy people, people with obesity, and people with type 2 diabetes. It aims to see how the drug affects blood sugar, weight, and overall safety. It may be an option if you have obesity or type 2 diabetes managed by diet and/or metformin.

Bayswater, Victoria
NCT07575932Recruiting· Phase 2
Testing New Weight Loss Medications PF-08653945 and PF-08653944

This study tests two new experimental medications designed to help adults lose weight and improve weight-related health conditions like high blood pressure and sleep apnea. Participants will take one of these medications to see if it's safe and effective.

Chandler, Arizona
NCT07339423Recruiting· Phase 3
A study of a new medicine for weight loss

This study tests a new medicine to see how well it helps people with excess body weight lose weight. It may be an option if you have tried to lose weight through dieting before but haven't had lasting success.

Miramar, Florida
NCT07503210Recruiting· Phase 3
Study of a new medicine to maintain weight loss

This study tests an investigational medicine to help people who have lost weight keep it off. It's for adults without diabetes who haven't used similar weight-loss drugs before.

Anniston, Alabama

Hear when a new Obesity and Obesity-related Medical Conditions trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.